Values as of: 2024-09-18
COMMON STOCK | Agricultural Inputs |
Last Closing
USD 11.29Change
0.00 (0.00)%Market Cap
USD 2.10BVolume
N/AAnalyst Target
N/AVerdict
Verdict
K+S Aktiengesellschaft, together with its subsidiaries, operates as a supplier of mineral products for the agricultural, industrial, consumer, and community sectors worldwide. It offers potassium chloride for crops, such as grain, corn, rice, and soybean; fertilizer specialties that are used for crops with magnesium and sulfur requirements, including rapeseed and potatoes, as well as for chloride-sensitive crops consisting of citrus, grapes, and vegetables; and water-soluble fertilizers for use in fertigation of fruit and vegetables under the KALISOP, KORN-KALI, ROLL-KALI, PATENTKALI, ESTA KIESERIT, MAGNESIA-KAINIT, SOLUMOP, SOLUSOP, SOLUCMS, SOLUMAP, SOLUMKP, EPSO TOP, EPSO MICROTOP, EPSO COMBITOP, EPSO PROFITOP, and EPSO BORTOP brands. The company also provides melting salts, sodium chloride, natural rock salt, high-purity vaccum salt and natural sea salt, potassium chloride, Epsom salt, minerals for pets and livestock, aluminum recycling, salt licks for farm and wild animals under the Alasal, APISAL, AXAL PRO, NUTRIKS, NUTRIKS KaliSel, KASA, k-DRILL, Montanal, and SOLSEL brand names. In addition, it offers table salts under the SALDORO, Cérébos, and Vatel brands; salts for water treatment; dishwashing salts; and de-icing salts. K+S Aktiengesellschaft was founded in 1889 and is headquartered in Kassel, Germany.
Company Website : https://www.kpluss.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| YRAIF | Yara International ASA |
N/A |
USD 7.28B |
| KNKZF | KWS SAAT SE & Co. KGaA |
N/A |
USD 2.44B |
| BWEL | Boswell J G Co |
-18.00 (-3.13%) |
USD 0.54B |
| VRDR | Verde Resources Inc |
N/A |
USD 0.24B |
| MBCF | Itafos Inc |
-0.05 (-4.27%) |
USD 0.22B |
| WYNSF | Wynnstay Group Plc |
N/A |
USD 0.13B |
| SGTM | National Storm Recovery Inc |
N/A |
USD 0.07B |
| GNVR | GNVR |
N/A |
USD 0.04B |
| MGROF | Mustgrow Biologics Corp |
-0.03 (-4.37%) |
USD 0.04B |
| KNGW | Kenongwo Group US Inc |
N/A |
USD 0.03B |
N/A
| Market Performance vs. Industry/Classification (Agricultural Inputs) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -28.54% | 35% | F | 28% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -28.54% | 33% | F | 27% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -39.04% | 42% | F | 28% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -39.04% | 42% | F | 28% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -33.78% | 48% | F | 46% | F | ||
| Dividend Return | 0.23% | 20% | F | 4% | F | ||
| Total Return | -33.55% | 48% | F | 44% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 29.72% | 69% | C- | 70% | C- | ||
| Dividend Return | 29.80% | 69% | C- | 68% | D+ | ||
| Total Return | 0.08% | 11% | F | 5% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 69.01% | 56% | F | 42% | F | ||
| Risk Adjusted Return | 43.19% | 83% | B | 80% | B- | ||
| Market Capitalization | 2.10B | 92% | A | 79% | B- | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
